The emerging treatment of tirzepatide peptide represents a significant development in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide affects dual pathways – GLP-1 and GIP https://tirzepatidepeptide883269.blogacep.com/47675786/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment